THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN

Volume: 12 Number: 2 December 3, 2016
  • Mithat Erenus
  • Ulun Uluğ
  • Alin Başgül
EN

THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN

Abstract

Objective: The purpose of this prospective study is to investigate the impact of adding active vitamin D metabolite to hormone replacement therapy (HRT) in the treatment of osteoporosis in early postmenopausal women.
Methods: Fifty-two naturally postmenopausal women receiving either 0.625 mg conjugated estrogen with 2.5 mg medroxyprogesterone acetate daily for 12 months or 0.50 pgr one alpha cholecalciferol in addition to 0.625 mg conjugated estrogen with 2.5 mg medroxyprogesterone acetate daily for 12 months.
Results: Bone mass density (BMD) increases significantly in both treatment groups at 12 months not only in proximal femur but in the lumbar spine as well. In the HRT + alpha calcidiol group, the percentage of change in BMD for the proximal femur was 17.32 ± 22.41 and 15.02 ± 10.05 for the lumbar spine. In the HRT alone treatment group the percentage of change in BMD was 12.21 ± 12.81 and 9.44 ± 8.01 for the proximal femur and the lumbar spine respectively.
Conclusion: Addition of vitamin D metabolite seemed to potentiate the BMD elevating effect of HRT even though the positive trend in the BMD change was not statistically significant in one year.
Key Words: Alpha calcidiol, Bone Density, Hormone Replacement Therapy.

References

  1. Quesada- Gomez JM, Alanso J, Bovillan R. Vitamin D insufficiency as a determinant of hip fractures. Osteoporos Int I996;(supp !3):42-47.
  2. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin Dj and calcium to prevent hip fractures in elderly women. b Engl J Med 1992;327:1637-1642.
  3. Lips F, Graafmans WC, Ooms ME, et al. The effect of vitamin D supplementation on the incidence of hip fractures in elderly people. J Bone Miner Res I994;(suppl I ¡.abstract 112.
  4. Slovik DM, Adams JS, beer RM, flolick MF, Potts JT, Jr. Deficient production of 1,25 dihydroxy vitamin D in elderly osteoporotic patients, b. Engl J Med 1981;305:372-374.
  5. lshibe M, bojima T, Ishiabishi T, et al. I 73- estradiol increases the receptor number and modulates the action of 1,25 dihydroxy vitamin Dj in human
  6. osteosarcoma derived osteoblast like celts. C.alc.if Tissue Int 1995:57:430-435.
  7. banjo M, Ichikawa F, fliguchi Y, et al. The mechanism of action, metabolism and distribution of I alpha hydroxycholecalciferol in bone. Bone Miner 1992;17:99-102.
  8. Imai Y, Fukase M, Mori S, et al. Effect of long term administration of alfa calcidiol on bone mineral density in involutional osteoporosis. Fourth international symposium on osteoporosis and consensus development conference, Hong Kong. Abstracts: 1993:114.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Mithat Erenus This is me

Ulun Uluğ This is me

Alin Başgül This is me

Publication Date

December 3, 2016

Submission Date

May 4, 2016

Acceptance Date

-

Published in Issue

Year 1999 Volume: 12 Number: 2

APA
Erenus, M., Uluğ, U., & Başgül, A. (2016). THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN. Marmara Medical Journal, 12(2), 63-66. https://izlik.org/JA86DC95HS
AMA
1.Erenus M, Uluğ U, Başgül A. THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN. Marmara Med J. 2016;12(2):63-66. https://izlik.org/JA86DC95HS
Chicago
Erenus, Mithat, Ulun Uluğ, and Alin Başgül. 2016. “THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN”. Marmara Medical Journal 12 (2): 63-66. https://izlik.org/JA86DC95HS.
EndNote
Erenus M, Uluğ U, Başgül A (June 2, 2016) THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN. Marmara Medical Journal 12 2 63–66.
IEEE
[1]M. Erenus, U. Uluğ, and A. Başgül, “THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN”, Marmara Med J, vol. 12, no. 2, pp. 63–66, June 2016, [Online]. Available: https://izlik.org/JA86DC95HS
ISNAD
Erenus, Mithat - Uluğ, Ulun - Başgül, Alin. “THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN”. Marmara Medical Journal 12/2 (June 2, 2016): 63-66. https://izlik.org/JA86DC95HS.
JAMA
1.Erenus M, Uluğ U, Başgül A. THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN. Marmara Med J. 2016;12:63–66.
MLA
Erenus, Mithat, et al. “THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN”. Marmara Medical Journal, vol. 12, no. 2, June 2016, pp. 63-66, https://izlik.org/JA86DC95HS.
Vancouver
1.Mithat Erenus, Ulun Uluğ, Alin Başgül. THE IMPACT OF VITAMIN D3 METABOLITE TO HORMONE REPLACEMENT THERAPY ON BONE DENSITY IN EARLY POSTMENOPAUSAL WOMEN. Marmara Med J [Internet]. 2016 Jun. 2;12(2):63-6. Available from: https://izlik.org/JA86DC95HS